Clinical Trials Browser

Terminated × Myelodysplastic Syndromes × Deferasirox × Clear all

NCT00602446 2017-12-28

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

BreastCNSGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Breast Neoplasms, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Neuroblastoma, Ovarian Neoplasms, Iron Overload, Neoplasms, Plasma Cell